Anti-Infective Drugs Market by Product Type, Distribution Channel, and Region – Global Market Size Estimation, Industry-Wide Analysis, Competitive Landscape Assessment & Long-Term Forecast to 2029
Overview
Anti-infective drugs Market size is expected to reach US$ 215.36 Bn. by year 2029 at a CAGR of 8% during the forecast period.
Anti-infective drugs Market Drivers and Restrains
The technological advances in anti-viral and antibiotic compounds are currently anti-infective drugs market, including Truvada and Valtrex, which are anti-HIV and anti-herpes therapy drugs, which are expected to fuel global anti-infective drug market.
Anti-infective drug is capable of acting against infection by inhibiting the spread of an infectious agent or by killing the infectious agent outright.It is a general term that encompasses antibacterials, antibiotics, antifungals, antiprotozoans and antivirals.
To know about the Research Methodology :- Request Free Sample Report
Developments such as stem cells and organ-on-chip (OOC) technologies. OOCs are micro-engineered biometric systems that simulate the activities, mechanics and physiological responses of organ systems would propel the global anti-infective drugs market. Factors such as patent expiration of drugs, pricing pressures from regulators, and low returns on investments would hinder the global Anti-infective drugs market in forecast period.
In January 2018, Melinta Therapeutics, Inc. launched its intravenous and oral formulations of Baxdela (delafloxacin) in the U.S. Baxdela is intended for the treatment of acute bacterial skin and skin structure infections (ABSSSI) caused by designated susceptible bacteria including gram positive bacteria and gram negative bacteria. This step would drive the global Anti-infective drugs market and is anticipated to maintain its dominance in forecast period.
Anti-infective drugs Market key segmentation
The antibiotics market is further segmented by product into -lactams, quinolones, macrolides, aminoglycosides and others. The antivirals market is further segmented by therapeutic type into HIV AIDS therapeutics, hepatitis therapeutics, influenza therapeutics, and herpes therapeutics. The antifungals market is further segmented by product into azoles and others. The Antibacterial market is further segmented as Aminoglycosides, Carbapenems, Cephalosporins, Macrolides, Penicillins, Quinolones, Sulfonamides, Tetracyclines and Others Calcium channel blockers.
Antiviral drug held highest share in terms of revenue of global Anti-infective drugs Market during the forecast period. rapid increase in the access to antiviral treatment of sexually transmitted diseases such as Hepatitis B and HIV/AIDS is expected to fuel this segment..
Increase in number of medical stores and hospitals are responsible for growth global Anti-infective drug market. Strong network of distribution channels around the countries have attributed to availability of anti-infectives that will affect the market in positive way. Also, major market players are focusing on expanding its geographical regions by focusing on distribution of anti-infectives in untapped markets of developing countries.
The hospitals provide extensive patient treatment, care, quick reimbursement, and insurance policies owing to which patients opt for hospital pharmacies.
Anti-infective drugs Market regional analysis
North America dominated the global anti-infective drug market in 2022. Changing healthcare market scenario and high awareness among end-users such as clinicians and healthcare professionals are estimated key factors responsible for this growth rate. Furthermore, high purchasing power for expensive drugs and the presence of favorable reimbursement policies are further attributed to fuel the regional market during the forecast period. Asia-Pacific witnesses significant CAGR over the forecast period heading to technological advances in drug discovery. Growing geriatric population coupled with increased susceptibility to infections is expected to provide a potential growth platform in the forecast period. It was followed by Western Europe and then the other regions. Going forward, Africa and Middle East will be the fastest growing regions in this market.
The objective of the report is to present comprehensive analysis of Global Anti-infective drugs Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of industry with dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give clear futuristic view of the industry to the decision makers.
The report also helps in understanding Global Anti-infective drugs Market dynamics, structure by analyzing the market segments, and project the Global market size. Clear representation of competitive analysis of key players by Anti-infective drugs Type, price, financial position, product portfolio, growth strategies, and regional presence in the Global Anti-infective drugs Market make the report investor’s guide.
Scope of the Global Anti-infective drugs Market: Inquire before buying
| Global Anti-Infective Drugs Market | |||
|---|---|---|---|
| Report Coverage | Details | ||
| Base Year: | 2022 | Forecast Period: | 2023-2029 |
| Historical Data: | 2018 to 2022 | Market Size in 2022: | US $ 125.66 Bn. |
| Forecast Period 2023 to 2029 CAGR: | 8% | Market Size in 2029: | US $ 215.36 Bn. |
| Segments Covered: | by Product | Antibiotics Antivirals Antifungals Antibacterial |
|
| by Distribution Channels | Retail Pharmacy Hospital Pharmacy Other |
||
Anti-infective drugs Market by region
North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)
Anti-infective drugs Market Key Players are:
1.Gilead Sciences,
2.GlaxoSmithKline,
3.Merck & Co,
4.Teva Pharmaceutical Industries Ltd.,
5.Johnson & Johnson
6.Pfizer Inc.
7.Abbott Laboratories
8.Gilead Sciences, Inc.
9.Bristol-Myers Squibb Co.
10.Bayer Healthcare AG
11.AstraZeneca Plc.
12.Boehringer Ingelheim
13.Novartis AG
14.Astellas Pharma, Inc.
15.GlaxoSmithKline Plc.
16.Alcon Pharmaceuticals Ltd.
17.Sanofi-Aventis S.A.
18.Melinta Therapeutics, Inc.
19.F. Hoffmann-La Roche Ltd
20.Hetero
21.Mylan N.V.
22.Aurobindo Pharma
23.Cipla Inc
24.Laurus Labs Ltd
25.Sun Pharmaceutical Industries Ltd
Frequently Asked questions
1. What is the market size of the Global Anti-Infective Drugs Market in 2022?
Ans. The market size Global market in 2022 was US$ 125.66 Billion.
2. What are the different segments of the Global Anti-Infective Drugs Market?
Ans. The Global market is divided into Product and Distribution Channel.
3. What is the study period of this market?
Ans. The Global Anti-Infective Drugs Market will be studied from 2022 to 2029.
4. Which region is expected to hold the highest Global Anti-Infective Drugs Market share?
Ans. The Asia Pacific dominates the market share in the market.
5. What is the Forecast Period of Global Anti-Infective Drugs Market?
Ans. The Forecast Period of the market is 2023-2029 in the market.